PubRank

Blood

Journal PubWeight™ 48054.06‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. 2009 23.52
2 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. 1994 21.00
3 International scoring system for evaluating prognosis in myelodysplastic syndromes. 1997 20.41
4 Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. 2008 20.32
5 Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. 2003 20.10
6 Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation. 1951 19.60
7 HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. 2006 17.38
8 Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. 1995 16.81
9 Biologic basis for interleukin-1 in disease. 1996 16.04
10 Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. 1975 15.95
11 Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. 2009 15.95
12 Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. 2003 13.92
13 Human mesenchymal stem cells modulate allogeneic immune cell responses. 2004 13.79
14 National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. 1996 13.35
15 Improved survival in multiple myeloma and the impact of novel therapies. 2007 12.70
16 Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). 2002 12.46
17 WHO-EORTC classification for cutaneous lymphomas. 2005 12.14
18 The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. 1998 11.58
19 Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. 1999 11.57
20 Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. 1999 11.50
21 Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 2004 11.07
22 A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. 1997 11.04
23 The World Health Organization (WHO) classification of the myeloid neoplasms. 2002 10.87
24 Adult T-cell leukemia: clinical and hematologic features of 16 cases. 1977 10.69
25 Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. 2005 10.63
26 BCG in the treatment of acute lymphocytic leukemia. 1975 9.88
27 High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. 2007 9.82
28 Chemokines. 1997 9.80
29 Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. 2000 9.60
30 SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE. 1965 9.42
31 Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. 2002 9.40
32 Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. 2000 9.24
33 Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. 2009 9.24
34 Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. 1994 9.10
35 The molecular classification of multiple myeloma. 2006 8.77
36 Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. 2002 8.76
37 Leukocyte-endothelial adhesion molecules. 1994 8.62
38 Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. 2006 8.56
39 Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. 2006 8.38
40 Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. 2005 8.37
41 Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. 2006 8.33
42 B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. 2011 8.26
43 Revised international prognostic scoring system for myelodysplastic syndromes. 2012 8.12
44 European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. 2013 8.00
45 AC133, a novel marker for human hematopoietic stem and progenitor cells. 1997 7.84
46 NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. 2002 7.78
47 Some speculations on the myeloproliferative syndromes. 1951 7.78
48 New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. 2008 7.73
49 International consensus report on the investigation and management of primary immune thrombocytopenia. 2009 7.72
50 Endothelial cells in physiology and in the pathophysiology of vascular disorders. 1998 7.70
Next 50